Rodríguez López, Carmen María Author
Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital
- Calandre E.
- Rodriguez?Lopez C.
- Blazquez A.
- Cano D.
Acta Neurologica Scandinavica - 1/1/1991
10.1111/j.1600-0404.1991.tb04691.x
- CiteScore: 5.8 (2020)
Dimensionality, reliability, and validity of the revised fibromyalgia impact questionnaire in two spanish samples
- Luciano J.
- Aguado J.
- Serrano-Blanco A.
- Calandre E.
- Rodriguez-Lopez C.
ARTHRITIS CARE and RESEARCH - 1/10/2013
- SJR Quartile: Q1
- JCR Impact Factor: 4.039 (2013)
- CiteScore: 8.2 (2020)
- SJR: 2.501 (2013
- SNIP: 1.921 (2013
- JCR 5-year Impact Factor: 4.753
- JCR Categories: RHEUMATOLOGY
- SJR Categories: Rheumatology (Q1)
- Scopus
- ORCID
- Web of Science
Trazodone for the treatment of fibromyalgia: an open-label, 12-week study.
- Morillas-Arques P
- Rodriguez-Lopez CM
- Molina-Barea R
- Rico-Villademoros F
- Calandre EP
BMC musculoskeletal disorders - 10/9/2010
- SJR Quartile: Q1
- JCR Impact Factor: 1.941 (2010)
- JCR 5-year Impact Factor: 2.375
- JCR Categories: RHEUMATOLOGY
- SJR Categories: Orthopedics and Sports Medicine (Q1); Rheumatology (Q2)
- ORCID
- Web of Science
Trazodone plus pregabalin combination in the treatment of fibromyalgia: A two-phase, 24-week, open-label uncontrolled study
- Calandre E.
- Morillas-Arques P.
- Molina-Barea R.
- Rodriguez-Lopez C.
- Rico-Villademoros F.
BMC MUSCULOSKELETAL DISORDERS - 18/5/2011
- SJR Quartile: Q1
- JCR Impact Factor: 1.577 (2011)
- CiteScore: 2.27 (2018)
- SJR: 0.89 (2011
- SNIP: 1.118 (2011
- JCR 5-year Impact Factor: 2.324
- JCR Categories: RHEUMATOLOGY
- SJR Categories: Orthopedics and Sports Medicine (Q1); Rheumatology (Q2)
- Scopus
- ORCID
- Web of Science
Pregabalin in the treatment of chronic migraine: An open-label study
- Calandre E.
- Garcia-Leiva J.
- Rico-Villademoros F.
- Vilchez J.
- Rodriguez-Lopez C.
CLINICAL NEUROPHARMACOLOGY - 1/1/2010
- SJR Quartile: Q2
- JCR Impact Factor: 1.578 (2010)
- CiteScore: 2.6 (2020)
- SJR: 0.634 (2010
- SNIP: 0.673 (2010
- JCR 5-year Impact Factor: 2.065
- JCR Categories: CLINICAL NEUROLOGY
- SJR Categories: Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)
- Scopus
- ORCID
- Web of Science
Amisulpride in the treatment of fibromyalgia: an uncontrolled study.
- Rico-Villademoros F.
- Rodriguez-Lopez C.
- Morillas-Arques P.
- Vilchez J.
- Hidalgo J.
- Calandre E.
Clinical rheumatology - 1/09/2012
- SJR Quartile: Q2
- JCR Impact Factor: 2.037 (2012)
- CiteScore: 4.5 (2020)
- SJR: 0.817 (2012
- SNIP: 1.1 (2012
- JCR 5-year Impact Factor: 1.866
- JCR Categories: RHEUMATOLOGY
- SJR Categories: Medicine (miscellaneous) (Q2); Rheumatology (Q2)
- Scopus
- ORCID
- Web of Science
The effects of gluten-free diet versus hypocaloric diet among patients with fibromyalgia experiencing gluten sensitivity symptoms: protocol for a pilot, open-label, randomized clinical trial.
- Slim M.
- Molina-Barea R.
- Garcia-Leiva J.
- Rodríguez-Lopez C.
- Morillas-Arques P.
- Rico-Villademoros F.
- Calandre E.
Contemporary clinical trials - 1/01/2015
- JCR Quartile: Q3 (2015)
- SJR Quartile: Q1
- JCR Impact Factor: 2.052 (2022)
- Category normalized Impact: 0.486 (2015)
- CiteScore: 3.3 (2020)
- SJR: 1.249 (2015
- SNIP: 0.924 (2015
- JCR 5-year Impact Factor: 2.028
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
- SJR Categories: Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1)
- Scopus
- ORCID
- Web of Science
Monotherapy or combination therapy for fibromyalgia treatment
- Calandre E.
- Rico-Villademoros F.
- Rodríguez-López C.
Current Rheumatology Reports - 1/12/2012
- SJR Quartile: Q1
- JCR Impact Factor: 3.873 (2022)
- Category normalized Impact: 0.453 (2012)
- CiteScore: 6.6 (2020)
- SJR: 1.124 (2012
- SNIP: 1.104 (2012
- SJR Categories: Rheumatology (Q1)
- Scopus
- ORCID
- Web of Science
[Use of aminoglycoside antibiotics in a general hospital: kinetics consequences in those patients whose blood levels are not monitored]
- Saucedo R
- Ortego Centeno N
- Mota MC
- López Ruz MA
- Rodríguez López CM
- López de Heredia E
- García Delgado R
Enfermedades infecciosas y microbiologia clinica - 1989
- ORCID
Ozone therapy as add-on treatment in fibromyalgia management by rectal insufflation: An open-label pilot study
- Hidalgo-Tallón J.
- Menéndez-Cepero S.
- Vilchez J.
- Rodríguez-López C.
- Calandre E.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE - 1/3/2013
- JCR Quartile: Q2 (2013)
- SJR Quartile: Q1
- JCR Impact Factor: 1.518 (2013)
- Category normalized Impact: 0.615 (2013)
- CiteScore: 3.5 (2020)
- SJR: 0.519 (2013
- SNIP: 1.057 (2013
- JCR 5-year Impact Factor: 1.985
- JCR Categories: INTEGRATIVE & COMPLEMENTARY MEDICINE
- SJR Categories: Complementary and Alternative Medicine (Q1)
- Scopus
- ORCID
- Web of Science
This author has no conferences.
This author has no patents.
Pregabalin effectiveness and tolerability in the prophylactic treatment of chronic migraine (2007) 27(10) 1179 (10.1111/j.1468-2982.2007.01481.x)
- Calandre E.
- Garcia-Leiva J.
- Rodriguez-Lopez C.
- Rico-Villademoros F.
Cephalalgia - 1/1/2007
10.1111/j.1468-2982.2007.01481.x
- SJR Quartile: Q1
- CiteScore: 8.1 (2020)
- SJR: 1.143 (2007
- SNIP: 1.211 (2007
- SJR Categories: Medicine (miscellaneous) (Q1); Neurology (clinical) (Q1)
h index
Scopus: 13
Web of Science: 14
i10 index
Scopus: 13
Web of Science: 17
Author profiles
-
ORCID
-
Scopus Author ID
Research projects at UAL
- This author has no currently assigned projects.